-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 V58kpzmDAgj4HJKag4Eonk6mKba2/i1JeM8KGwNIKt7AtOsBDaG9fWFwBBQOT4CB
 9N4L6tvN63+jJCjfU0RXQg==

<SEC-DOCUMENT>0000910662-07-000302.txt : 20080314
<SEC-HEADER>0000910662-07-000302.hdr.sgml : 20080314
<ACCEPTANCE-DATETIME>20070628085636
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000910662-07-000302
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20070628

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PRANA BIOTECHNOLOGY LTD
		CENTRAL INDEX KEY:			0001131343
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 2
		STREET 2:		369 ROYAL PARADE
		CITY:			PARKVILLE, VICTORIA
		STATE:			C3
		ZIP:			3052
		BUSINESS PHONE:		61-3-9349-4906

	MAIL ADDRESS:	
		STREET 1:		LEVEL 2
		STREET 2:		369 ROYAL PARADE
		CITY:			PARKVILLE, VICTORIA
		STATE:			C3
		ZIP:			3052
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
                          CARTER LEDYARD & MILBURN LLP
                                Counselors at Law

                                  2 Wall Street
                             New York, NY 10005-2072       701 8th Street, N.W.,
                                                                 Suite 410
                                                       Washington, DC 20001-3893
    Steven J. Glusband                 o                       (202) 898-1515
          Partner                                                     o
             o                Tel (212) 732-3200          570 Lexington Avenue
 Direct Dial: 212-238-8605    Fax (212) 732-3232         New York, NY 10022-6856
 E-mail: glusband@clm.com                                    (212) 371-2720


                                            June 28, 2007

VIA EDGAR
- ---------

Mr. Jim B. Rosenberg
Senior Assistant Chief Accountant
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

                      Re:   Prana Biotechnology Limited
                            Form 20-F for Fiscal Year Ended June 30, 2006
                            Form 20-F/A for the Fiscal Year Ended June 30, 2006
                            File No. 0-49843
                            ----------------

Dear Mr. Rosenberg:

         In furtherance of my telephone conversation with Mr. Mark Brunhofer of
the Staff, I am able to confirm that our client, Prana Biotechnology Ltd. (the
"Company"), will respond by July 21, 2007 to the Staff's comments contained in a
letter addressed to Mr. Geoffrey P. Kempler, Chief Executive Officer of the
Company, dated June 21, 2007.

         Thank you again for your cooperation.

                                            Very truly yours,

                                            /s/ Steven J. Glusband
                                            Steven J. Glusband

SJG:tco

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
